Beneficial effects of the melanocortin analogue Nle4-D-Phe 7-α-MSH in acne vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 1, 2014, Pages 108-111

  Bohm M ^a   Ehrchen, J ^a   Luger, T A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AFAMELANOTIDE; ELECTROLYTE; MELANIN;

ACNE VULGARIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CELL COUNT; CASE REPORT; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DRUG EFFICACY; FATIGUE; HUMAN; HYPERPIGMENTATION; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN PIGMENTATION; SPECTROPHOTOMETRY; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; URINALYSIS;

ACNE VULGARIS; ALPHA-MSH; DRUG IMPLANTS; HUMANS; PILOT PROJECTS; QUALITY OF LIFE;

EID: 84890559387     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04658.x     Document Type: Article

References (17)

1. Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584-1590.
2. Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821-832.
3. Böhm M,. Neuroendocrine regulators: novel trends in sebaceous gland research with future perspectives for the treatment of acne and related disorders. Dermatoendocrinology 2009; 1: 136-140.
4. Thody AJ, Cooper MF, Bowden PE, et al. Effect of α-melanocyte- stimulating hormone and testosterone on cutaneous and modified sebaceous glands in the rat. J Endocrinol 1976; 71: 279-288.
5. Chen W, Kelly MA, Opitz-Araya X, et al. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997; 91: 789-798.
6. Thiboutot D, Sivarajah A, Gilliland K, et al. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Invest Dermatol 2001; 115: 614-619.
7. Böhm M, Schiller M, Li Z, et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539.
8. Zhang L, Li W-H, Anthonavage M, et al. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 2006; 27: 413-420.
9. Harms J, Minder CE, Minder EI,. An alpha-melanocyte-stimulating analogue in erythropoietic protoporphyria. New Engl J Med 2009; 360: 306-307.
10. Haylett AK, Nie Z, Brownrigg M, et al. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH. Br J Dermatol 2011; 164: 407-414.
11. Brzoska T, Luger TA, Maaser C, et al. α-Melanocyte-stimulating hormone and related tripeptides. Biochemistry, anti-inflammatory effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Rev 2008; 29: 561-602.
12. James KA, Burkhart CN, Morrell DS,. Emerging drugs for acne. Expert Opin Emerg Drugs 2009; 14: 649-659.
13. Catania A, Rajora N, Capsoni F, et al. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996; 17: 675-679.
14. Schiller M, Brzoska T, Böhm M, et al. Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo. J Invest Dermatol 2004; 122: 468-476.
15. Degitz K,. Phototherapy, photodynamic therapy and lasers in the treatment of acne. J Dtsch Dermatol Ges 2009; 7: 1048-1054.
16. Cutuli M, Cristiani S, Lipton JM, et al. 2000 Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 2000; 67: 233-239.
17. Zhang L, Anthonagae M, Huang Q, et al. Proopiomelanocortin peptides and sebogenesis. Ann NY Acad Sci 2003; 994: 154-161.